Catalyst Wire Dossier Catalyst Wire Dossier

FASENRA

BENRALIZUMAB · AstraZeneca Pharmaceuticals LP
Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for FASENRA, covering 2017-01-25 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

See pricing